Notis-McConarty Edward’s Gilead Sciences GILD Stock Holding History

Notis-McConarty Edward’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$711K	Hold	5,100	–	–	0.35%	46
2025 Q4	$626K	Hold	5,100	–	–	0.29%	48
2025 Q3	$566K	Hold	5,100	–	–	0.26%	54
2025 Q2	$565K	Hold	5,100	–	–	0.28%	55
2025 Q1	$571K	Hold	5,100	–	–	0.29%	50
2024 Q4	$471K	Hold	5,100	–	–	0.23%	58
2024 Q3	$428K	Hold	5,100	–	–	0.19%	59
2024 Q2	$350K	Hold	5,100	–	–	0.14%	74
2024 Q1	$374K	Hold	5,100	–	–	0.15%	75
2023 Q4	$413K	Hold	5,100	–	–	0.16%	72
2023 Q3	$382K	Hold	5,100	–	–	0.16%	78
2023 Q2	$393K	Hold	5,100	–	–	0.15%	81
2023 Q1	$423K	Hold	5,100	–	–	0.17%	78
2022 Q4	$438K	Sell	5,100 -200	-4%	-$15.8K	0.18%	78
2022 Q3	$327K	Hold	5,300	–	–	0.15%	83
2022 Q2	$328K	Sell	5,300 -2,800	-35%	-$173K	0.14%	86
2022 Q1	$482K	Hold	8,100	–	–	0.17%	84
2021 Q4	$588K	Hold	8,100	–	–	0.2%	78
2021 Q3	$566K	Buy	8,100 +600	+8%	+$42.2K	0.21%	77
2021 Q2	$516K	Sell	7,500 -500	-6%	-$33.4K	0.19%	80
2021 Q1	$517K	Sell	8,000 -500	-6%	-$32.2K	0.2%	75
2020 Q4	$495K	Sell	8,500 -2,500	-23%	-$151K	0.2%	75
2020 Q3	$695K	Hold	11,000	–	–	0.31%	67
2020 Q2	$846K	Hold	11,000	–	–	0.39%	61
2020 Q1	$822K	Sell	11,000 -2	-0%	-$138	0.46%	58
2019 Q4	$715K	Hold	11,002	–	–	0.32%	68
2019 Q3	$698K	Sell	11,002 -10	-0.1%	-$654	0.33%	68
2019 Q2	$744K	Hold	11,012	–	–	0.35%	67
2019 Q1	$716K	Sell	11,012 -175	-2%	-$11.6K	0.35%	67
2018 Q4	$700K	Sell	11,187 -30	-0.3%	-$2.1K	0.39%	65
2018 Q3	$867K	Sell	11,217 -3,725	-25%	-$281K	0.46%	54
2018 Q2	$1.06M	Sell	14,942 -330	-2%	-$23.3K	0.63%	50
2018 Q1	$1.15M	Buy	15,272 +75	+0.5%	+$5.96K	0.69%	48
2017 Q4	$1.09M	Hold	15,197	–	–	0.63%	51
2017 Q3	$1.23M	Sell	15,197 -1,485	-9%	-$114K	0.77%	43
2017 Q2	$1.18M	Hold	16,682	–	–	0.76%	43
2017 Q1	$1.13M	Buy	16,682 +2,435	+17%	+$171K	0.74%	46
2016 Q4	$1.02M	Sell	14,247 -3,920	-22%	-$291K	0.7%	46
2016 Q3	$1.44M	Buy	18,167 +2,065	+13%	+$168K	0.98%	35
2016 Q2	$1.34M	Buy	16,102 +2,792	+21%	+$248K	0.94%	40
2016 Q1	$1.22M	Buy	13,310 +4,110	+45%	+$371K	0.87%	40
2015 Q4	$931K	Hold	9,200	–	–	0.67%	49
2015 Q3	$903K	Hold	9,200	–	–	0.68%	48
2015 Q2	$1.08M	Sell	9,200 -500	-5%	-$54.6K	0.73%	43
2015 Q1	$952K	Sell	9,700 -300	-3%	-$30.5K	0.66%	48
2014 Q4	$943K	Hold	10,000	–	–	0.65%	46
2014 Q3	$1.06M	Sell	10,000 -500	-5%	-$49K	0.75%	45
2014 Q2	$871K	Sell	10,500 -500	-5%	-$38.9K	0.58%	52
2014 Q1	$779K	Sell	11,000 -1,300	-11%	-$102K	0.54%	58
2013 Q4	$924K	Buy	+12,300	New	+$856K	0.65%	51

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Notis-McConarty Edward's GILD Position: Q1 2026 in Review

Notis-McConarty Edward held its Gilead Sciences (GILD) position steady in Q1 2026 at 5,100 shares worth $711K. The position accounts for 0.35% of the portfolio, ranked #46.

Notis-McConarty Edward first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.44M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Notis-McConarty Edward held 5,100 shares of Gilead Sciences worth $711K as of Q1 2026.
Notis-McConarty Edward left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.35% of Notis-McConarty Edward's portfolio in Q1 2026, its #46 holding.
Notis-McConarty Edward first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
Notis-McConarty Edward's Gilead Sciences position peaked at $1.44M in Q3 2016.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.